Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new revision line 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' was removed, updating the page's revision history.
    Difference
    0.0%
    Check dated 2026-09-01T19:01:02.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    On 2026-08-06, the study record adds a Results Posted entry and updates the open-label extension to allow either dose B or dose C with specified follow-up weeks. Enrollment is listed as 160, and several secondary outcomes and eligibility details have been revised to reflect the new design and reporting status.
    Difference
    1%
    Check dated 2026-08-11T19:51:00.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Results status on the study page now shows 'Results Submitted,' replacing the previous 'No Results Posted.' The page revision has been updated to v3.6.4 from v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-21T13:16:08.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.3, indicating a new edition of the page. This change reflects minor edits or fixes applied to the page without altering its core content.
    Difference
    0.0%
    Check dated 2026-06-30T02:30:44.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Recruitment status now shows 'No longer looking for participants', indicating that participant enrollment has closed, while new navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The label for Intervention/Treatment has been standardized to 'Intervention/Treatment' and the site revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T22:00:48.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 for the page, indicating a minor update to the ClinicalTrials.gov entry. There is no indication that study content or eligibility criteria were modified.
    Difference
    0.0%
    Check dated 2026-06-08T18:15:21.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.